Zelnorm and Yaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zelnorm (tegaserod maleate) and Yaz (drospirenone; ethinyl estradiol). Common drug interactions include cholelithiasis among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Zelnorm and Yaz. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Zelnorm?

Zelnorm has active ingredients of tegaserod maleate. eHealthMe is studying from 7,261 Zelnorm users. Check the latest studies of Zelnorm.

What is Yaz?

Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,514 Yaz users. Check the latest studies of Yaz.



On Jul, 17, 2026

46 people who take Zelnorm and Yaz together, and have interactions are studied.

Zelnorm and Yaz drug interactions.

What are the common drug interactions of Zelnorm and Yaz, by gender? *:

female:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Injury
  4. Pain
  5. Abdominal pain
  6. Abdominal pain upper
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  9. Gallbladder disorder
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Asthma
  2. Bone marrow failure
  3. Abdominal pain
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  6. Blood creatinine increased
  7. Candida sepsis (candida in blood stream)
  8. Complications of transplanted kidney
  9. Loss of consciousness
  10. Peritoneal candidiasis (fungal infection in peritoneal)

What are the common drug interactions of Zelnorm and Yaz, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal pain
  2. Ascites (accumulation of fluid in the abdominal cavity)
  3. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  4. Blood creatinine increased
  5. Candida sepsis (candida in blood stream)
  6. Complications of transplanted kidney
  7. Loss of consciousness
  8. Peritoneal candidiasis (fungal infection in peritoneal)
  9. Post procedural infection
  10. Septic shock (shock due to blood infection)

2-9:

n/a

10-19:

  1. Injury
  2. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  3. Abdominal pain
  4. Abdominal pain upper
  5. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  6. Cholesterosis (abnormal deposition of cholesterol in tissues)

20-29:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Pain
  4. Abdominal pain upper
  5. Injury
  6. Abdominal tenderness
  7. Constipation
  8. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  9. Gallbladder disorder
  10. Abdominal pain

30-39:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Weight decreased
  4. Abdominal pain
  5. Vaginal haemorrhage (vaginal bleeding)
  6. Abdominal pain upper
  7. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  8. Blindness unilateral
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Dysarthria (speech disorder)

40-49:

  1. Chest pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Asthma
  5. Cholecystitis chronic (long lasting infection of gallbladder)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the)
  8. Gallbladder injury
  9. Lung neoplasm (tumour of lung)
  10. Abdominal pain

50-59:

  1. Asthma
  2. Bone marrow failure
  3. Chest pain
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  5. Dyspnoea (difficult or laboured respiration)
  6. General physical health deterioration (weak health status)
  7. Lung neoplasm (tumour of lung)
  8. Mucosal inflammation (infection of mucous membrane)
  9. Neoplasm progression (growth of tumour)
  10. Pulmonary embolism (blockage of the main artery of the lung)

60+:

n/a

What are the existing conditions these people have? *

  1. Acne (skin problems that cause pimples): 9 people, 19.57%
  2. Premenstrual Syndrome: 8 people, 17.39%
  3. Constipation: 7 people, 15.22%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 13.04%
  5. Depression: 5 people, 10.87%
  6. Menstruation Irregular: 5 people, 10.87%
  7. Irritable Bowel Syndrome: 5 people, 10.87%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.70%
  9. Ovarian Cysts (fluid filled sacs of the ovary): 4 people, 8.70%
  10. Herpes Virus Infection: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Zelnorm and Yaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zelnorm and Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zelnorm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tegaserod maleate and drospirenone; ethinyl estradiol (the active ingredients of Zelnorm and Yaz, respectively), and Zelnorm and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: